A. Price

发表

Phase III study of matrix metalloproteinase inhibitor prinomastat in non-small-cell lung cancer.

K. O'Byrne, F. Shepherd, D. Bissett, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965).

G. Giaccone, E. Smit, P. Postmus, 2003, European journal of cancer.

Is Radiotherapy Useful for Treating Pain in Mesothelioma?: A Phase II Trial

N. O'Rourke, A. Price, B. Laird, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Using Radiotherapy to Treat Pain in Mesothelioma

N. O'Rourke, A. Price, B. Laird, 2015 .

Radiotherapy for the treatment of pain in malignant pleural mesothelioma: a systematic review.

N. O'Rourke, A. Price, B. Laird, 2014, Lung cancer.

Reduced DNA-dependent protein kinase activity in two cell lines derived from adult cancer patients with late radionecrosis

A. Price, Svitlana Korzh, S. Loong, 2004, Oncogene.

What is the role of radiotherapy in malignant pleural mesothelioma?

A. Price, 2011, The oncologist.

Docetaxel-based induction therapy prior to radiotherapy with or without docetaxel for non-small-cell lung cancer

J. Debus, G. Scagliotti, R. Ramlau, 2006, British Journal of Cancer.

Lung cancer • 5: State of the art radiotherapy for lung cancer

A. Price, 2003, Thorax.

Overcoming CYP1A1/1A2 mediated induction of metabolism by escalating erlotinib dose in current smokers.

D. Dunlop, A. Price, M. Nicolson, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis.

H. Choy, R. Arriagada, J. Pignon, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Improving outcomes for limited stage small cell lung cancer patients in Scotland with concomitant chemoradiation.

G. Kerr, A. Price, S. Erridge, 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

Chemotherapy in patients with advanced non-small cell lung cancer.

A. Price, 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).

Patient accrual into chemotherapy trials in non-small cell lung cancer

A. Price, 2000, Thorax.

Improved Treatment and Survival for Lung Cancer Patients in South-East Scotland

A. Price, S. Erridge, M. Mackean, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Characterizing the phenomenon of radiation recall dermatitis.

R. Camidge, A. Price, 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Reframing the Concept of "No Treatment" in Advanced NSCLC.

A. Price, J. Bowden, S. Fenning, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Radical radiotherapy with or without gemcitabine in patients with early stage medically inoperable non-small cell lung cancer.

C. Faivre-Finn, A. Price, S. Erridge, 2012, Lung cancer.

A multi-centre phase IIB randomized controlled study of BLP25 liposome vaccine (L-BLP25 or Stimuvax) for active specific immunotherapy of non-small cell lung cancer (NSCLC): updated survival analysis: B1-01

P. Ellis, A. Price, Y. Cormier, 2007 .

Acute radiation pneumonitis after postmastectomy irradiation: effect of fraction size.

G. Kerr, A. Rodger, A. Price, 1990, Clinical oncology (Royal College of Radiologists (Great Britain)).

Intensity-modulated radiotherapy, not 3 dimensional conformal, is the preferred technique for treating locally advanced disease with high-dose radiotherapy: the argument against.

A. Price, 2015, Seminars in radiation oncology.

European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer.

Suresh Senan, Corinne Faivre-Finn, Ursula Nestle, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Explorer What Is the Role of Radiotherapy in Malignant Pleural Mesothelioma ?

A. Price, 2017 .

Malignant superior vena cava obstruction: Stent placement via the subclavian route

A. Price, John H. Miller, K. McBride, 2000, CardioVascular and Interventional Radiology.

Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: a multicenter, randomized, phase II trial.

G. Scagliotti, S. Novello, L. Crinò, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Radiation recall dermatitis may represent the Koebner phenomenon.

R. Camidge, A. Price, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial

P. Ellis, A. Price, Y. Cormier, 2011, Journal of Cancer Research and Clinical Oncology.

High-dose carboplatin and etoposide for salvage chemotherapy of germ cell tumours.

A. Horwich, J. Mehta, A. Price, 1995, European journal of cancer.

Randomized double-blind placebo-controlled trial of thalidomide in combination with gemcitabine and Carboplatin in advanced non-small-cell lung cancer.

A. Hackshaw, A. Price, P. Woll, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pentoxifylline to treat radiation proctitis: a small and inconclusive randomised trial.

D. Dearnaley, A. Horwich, R. Huddart, 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

Lung cancer v 5 : State of the art radiotherapy for lung cancer

A. Price, 2003 .

Three years of erlotinib in routine practice for non-small cell lung cancer in South East Scotland.

G. Kerr, A. Price, S. Erridge, 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

Emerging developments of chemoradiotherapy in stage III NSCLC

A. Price, 2012, Nature Reviews Clinical Oncology.

Need for a new trial to evaluate adjuvant postoperative radiotherapy in non-small-cell lung cancer patients with N2 mediastinal involvement.

J. Pignon, B. Milleron, D. de Ruysscher, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prediction of 90 Day and Overall Survival after Chemoradiotherapy for Lung Cancer: Role of Performance Status and Body Composition.

K. Fearon, A. Price, M. Fallon, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

Factors influencing the use of thoracic radiotherapy in lung cancer--an analysis of the 1995 Scottish lung cancer audit.

A. Price, S. Erridge, C. Thomson, 2002, Clinical oncology (Royal College of Radiologists (Great Britain)).

Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer.

P. Ellis, P. Ellis, A. Price, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973).

G. Giaccone, H. Bartelink, C. Koning, 2007, European journal of cancer.

Hypofractionated radiotherapy for patients with carcinoma of the bladder.

D. Dearnaley, A. Horwich, R. Huddart, 1999, Clinical oncology (Royal College of Radiologists (Great Britain)).

Haematological toxicity of radiotherapy following high-dose chemotherapy and autologous bone marrow transplantation in patients with recurrent Hodgkin's disease.

A. Horwich, A. Price, D. Cunningham, 1994, European journal of cancer.

Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052).

J. V. van Meerbeeck, A. Price, P. Baas, 2013, European journal of cancer.

New Level Set Model in Follow Up Radiotherapy Image Analysis

Stephen McLaughlin, Roushanak Rahmat, David Harris-Birtill, 2017, MIUA.

Symptom control and quality of life in people with lung cancer: a randomised trial of two palliative radiotherapy fractionation schedules.

A. Gregor, A. Cull, G. Kerr, 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).

Variations in target volume definition for postoperative radiotherapy in stage III non-small-cell lung cancer: analysis of an international contouring study.

D. de Ruysscher, S. Senan, J. R. van Sörnsen de Koste, 2010, International journal of radiation oncology, biology, physics.

Long-term survival in patients with non-small cell lung cancer treated with palliative radiotherapy.

A. Gregor, G. Kerr, A. Price, 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).

A Study of the Incidence and Management of Admissions for Cancer-related Symptoms in a District General Hospital: the Potential Role of an Acute Oncology Service.

A. Price, J. Smith, C. M. Bruce, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

Advanced radiotherapy techniques in stage IIIB non-small cell lung cancer

A. Price, S. Erridge, A. Reilly, 2007 .

Improved survival from lung cancer in British Columbia compared to Scotland-are different treatment rates the whole story?

A. Price, S. Erridge, F. Sheehan, 2009, Lung cancer.

Primary radiotherapy for T4 breast cancer.

G. Kerr, A. Rodger, A. Price, 1992, Clinics in oncology.

International comparisons of survival from lung cancer: pitfalls and warnings

A. Price, H. Møller, S. Erridge, 2007, Nature Clinical Practice Oncology.

A Phase I study of gemcitabine with concurrent radiotherapy in stage III, locally advanced non-small cell lung cancer.

H. Groen, A. Gregor, A. Price, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase II study of gemcitabine and cisplatin in locally advanced/metastatic oesophageal cancer

D. Dunlop, D. Cameron, A. Price, 2005, British Journal of Cancer.

GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine-cisplatin with vinorelbine-ifosfamide-cisplatin in metastatic non-small-cell lung cancer patients.

R. V. van Klaveren, U. Gatzemeier, A. Price, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

A patient with Rothmund-Thomson syndrome and tongue cancer--experience of radiation toxicity.

A. Price, M. Dahele, E. Benton, 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

Extramedullary plasmacytoma of the rectum: two cases treated by radiotherapy.

A. Price, P. Quilty, S. Ludgate, 1987, Clinical radiology.

The effect of overall treatment time on the survival and toxicity of radical radiotherapy for cervical carcinoma.

G. Kerr, A. Price, S. Erridge, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Patient Perceptions of Their Decision to Undergo Palliative Chemotherapy in the Edinburgh Cancer Centre

A. Price, B. Hacking, F. Nussey, 2019, The journal of the Royal College of Physicians of Edinburgh.

What is the role of radiotherapy in malignant pleural mesothelioma?

A. Price, 2011, The oncologist.